Association between proton pump inhibitors and hepatic encephalopathy: A meta-analysis

BACKGROUND & AIMS: Several studies have shown that proton pump inhibitors (PPIs) use can increase the risk of developing hepatic encephalopathy (HE) in patients with liver dysfunction. However, no definite conclusion is drawn because of study design limitations. Therefore, we conducted a meta-an...

Descripción completa

Detalles Bibliográficos
Autores principales: Bian, Jin, Wang, Anqiang, Lin, Jianzhen, Wu, Liangcai, Huang, Hanchun, Wang, Shanshan, Yang, Xiaobo, Lu, Xin, Xu, Yiyao, Zhao, Haitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413253/
https://www.ncbi.nlm.nih.gov/pubmed/28445288
http://dx.doi.org/10.1097/MD.0000000000006723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413253/
https://www.ncbi.nlm.nih.gov/pubmed/28445288
http://dx.doi.org/10.1097/MD.0000000000006723

Ejemplares similares